Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:Q06643 (non-Hodgkin's lymphoma)
 11,307 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Marginal zone B-cell lymphoma (MZBCL) including extranodal mucosa-associated lymphoid tissue (MALT)-type lymphoma, nodal, and splenic MZBCL represents a distinct subtype of B-non-Hodgkin's lymphoma. Recently, important progress in the elucidation of the genetic mechanisms underlying the pathogenesis and disease progression of these lymphomas has been made. The API2 gene, an inhibitor of apoptosis, and the novel MLT gene have been found to be altered by the t(11;18)(q21;21), which represents the most frequent structural chromosomal abnormality in extranodal low-grade MALT lymphoma. Another gene involved in the regulation of apoptosis, the BCL10 gene, has been cloned from a MALT lymphoma cytogenetically characterized by the t(1;14)(p22;q32). Along the same lines, inactivating mutations of the proapoptotic FAS gene have been detected in a relatively high proportion of extranodal MZBCLs. Considering these data and the fact that at least some MALT lymphomas show low levels of apoptosis and seem to escape from FAS-mediated apoptosis one may speculate that abrogation of apoptosis constitutes a central pathogenetic mechanism in the development of these lymphomas. The pathogenetic role of trisomy 3, the most frequent numerical chromosomal change of MZBCL, is not known. The minimal overrepresented region has been delineated to 3q21-23 and 3q25-29 using comparative genomic hybridization. The BCL6 proto-oncogene, located on 3q27, which is rearranged in some MZBCL and a high proportion of large cell B-cell lymphomas with extranodal localization, represents one of the candidate genes residing in these critical regions.
 ...
PMID:Genetic abnormalities in marginal zone B-cell lymphoma. 1079 25

Malathion is the most common organophosphate insecticide applied in the United States, and while some studies suggest that it may be clastogenic, its carcinogenicity has not been demonstrated in rodents. However, malathion has been associated with non-Hodgkin's lymphoma in several epidemiologic studies. The authors investigated associations between malathion exposure and cancer among 19,717 pesticide applicators enrolled in the Agricultural Health Study between 1993 and 1997. Information on lifetime years and days per year of use and intensity of malathion exposure was obtained with self-administered questionnaires prior to the onset of any cancer. The average follow-up time was 7.5 years (1993-2002). Rate ratios and 95% confidence intervals were calculated using Poisson regression, adjusting for potential confounders. Overall, lifetime days of malathion use (top tertile of exposure, >39 days) was not associated with all cancers combined (rate ratio = 0.97, 95% confidence interval: 0.81, 1.15). The risk of non-Hodgkin's lymphoma was not associated with malathion use, although the number of cases was small. The risk of melanoma with more than 39 lifetime exposure-days was 0.39 (95% confidence interval: 0.14, 1.03). In summary, malathion exposure was not clearly associated with cancer at any of the sites examined. Although the rate ratios for melanoma were reduced, small numbers and lack of experimental evidence suggest that the observed reductions may have arisen by chance.
 ...
PMID:Malathion exposure and the incidence of cancer in the agricultural health study. 1772 Jun 83

The descriptive epidemiology of non-Hodgkin's lymphoma (NHL) (1984-1988) in parts of England and Wales is described by low grade (LG) and high grade (HG) subtypes. Major differences in age specific incidence are evident particularly in those under 35 years where LG-NHL is virtually absent in childhood and rare in young adulthood. Over the 5 year period of registration of cases significant increases in incidence were noted for males with both HG and LG disease. The geographical analyses demonstrate clear epidemiological differences between LG-NHL and HG-NHL. The SMRs for 22 English and Welsh counties are not correlated for LG and HG-NHL disease, whose distributions are significantly different. Regression analyses at the electoral ward level show a strong association between LG-NHL and high-socio economic status and there is a weaker link between HG-NHL and residence in an urban area. Formal comparison of LG and HG-NHL shows significant differences for the effect of socio-economic grouping but not for urban-rural status. There is strong evidence to show that major differences exist in patterns of LG and HG-NHL for age specific incidence, geographical distribution and area risk factors. Interpretation of these epidemiological features are highly suggestive of differing aetiologies.
...
PMID:Epidemiology of Non-Hodgkin's Lymphoma in Parts of England and Wales (1984-1988). 2746 42